Filter
185
Filtered Results: 185
Text search:
dolutegravir
Featured
Recommendations
22
New Publications
43
Language
Document type
No document type
87
Guidelines
43
Studies & Reports
34
Manuals
9
Strategic & Response Plan
5
Fact sheets
3
Infographics
2
Training Material
1
Situation Updates
1
Countries / Regions
Global
7
Argentina
7
South Africa
7
Malawi
5
Latin America and the Carribbean
5
Kenya
4
Brazil
4
Colombia
3
Africa
3
Namibia
3
Venezuela
2
South–East Asia Region
2
Botswana
2
Myanmar / Burma
2
Nepal
1
Thailand
1
Ukraine
1
Lesotho
1
Chile
1
Nigeria
1
Burkina Faso
1
Peru
1
Zimbabwe
1
Philippines
1
Guinea
1
Mozambique
1
Congo, Democratic Republic of
1
Western Pacific Region
1
Western and Central Europe
1
North America
1
Bolivia
1
Uganda
1
Central African Republic
1
Ethiopia
1
Chad
1
Zambia
1
Somalia
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
32
HIV & STI
18
TB
7
Drugs & Medical Equipment
5
COVID-19
4
Guidelines
4
Pediatrics
3
Humanitarian Crisis
3
Paediatrics
2
Women & Child Health
2
Studies & Reports
2
Statistics
2
Pharmacy & Technologies
2
Communicable Diseases
1
Hepatitis
1
Emergency Health Kits
1
Buruli Ulcer
1
Countries
1
Policies
1
Capacity Building
1
Other
1
Maternal Health
1
Primary Health Care
1
Neurology & Psychology
1
Reproductive Health
1
Toolboxes
Antiretroviral Treatment ART
28
Clinical Aspects, Treatment & Prevention
22
ART Drug Resistance
16
Treatment & Prevention
15
Treatment Guidelines HIV
14
General Reports
13
Children & Adolescents
13
Global
8
Reports & Studies
7
Prevention & Control
6
Universal Health Coverage UHC and 90-90-90 Strategy
6
Essential Medicines & Devices Lists
6
Reports & Studies Children HIV
6
Policies
5
Drug resistance
5
Clinical Aspects
4
Adults
4
Essential Medicines
4
General Aspects
4
Opportunistic Infections
3
HIV and COVID-19
3
Co-Morbidities (except TB)
3
Prevention of mother-to-child transmission (PMTCT)
3
TB/HIV Coinfection
3
HIV service delivery
3
Lobby and Advocacy
3
Eastern Europe and central Asia
3
HIV testing & services
2
Prevention Guidelines
2
International
2
Essential List
2
Country specific documents
2
Brazil
2
Rational use of Medicine
2
Argentina
2
Access to treatment and laboratory
2
Detection & Diagnosis
2
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
2
Policies and guidelines
2
Depression
2
Eastern and Southern Africa
2
Drugs
1
Policies & Strategies
1
HIV support organizations
1
Childhood TB
1
Substance Use Disorders, Others
1
Schizophrenia
1
HIV
1
Others
1
Children
1
Health & Refugee
1
General
1
Laboratory
1
For General Public & Community
1
Global Impact: Socio-economic, health services, TB & HIV
1
Guidelines
1
Tips & Best Practice Examples
1
TB/HIV
1
Community Health Workers CHW
1
Colombia
1
Model Formulary
1
Mental Disorders
1
Situation Reports & Updates
1
General
1
Strategies & Roadmaps
1
Clinical Aspects & Diagnostics
1
West and central Africa
1
Health Worker
1
Drug resistant TB
1
Neurological Disorders
1
Substance Use Disorders & Addiction
1
Community Worker
1
Bipolar Affective Disorders
1
TB/HIV Global
1
Regions
1
Prophylactic Treatment
1
Training
1
HIV / AIDS
1
HIV and coinfection
1
Testing Guidelines
1
Epidemiology
1
Epidemiology
1
HIV in Key Populations
1
SEAR (South-east Asia Region)
1
Kenya Essential Medicines List 2019
recommended
The Kenya Essential Medicines List 2019 is an indispensable guide to the medicines recommended for the management of common conditions in Kenya. It is primarily directed at health care providers and medicines supply managers in the public and non-public health sectors. It should be used together wit...
The 7th edition of the Orange Guide provides practical guidance to health workers on the front line of TB control. It includes sections on HIV, MDR-TB and a review of the recommended treatment regimens
1PEP GUIDELINES | 2019 EDITION. The prevalence of both HIV and Hepatitis B is high in South Africa therefore there is a significant risk of acquiring these infections following exposure to infected material. Studies suggest that post- exposure prophylaxis (PEP) with highly active antiretroviral trea...
May 2018
HIV i-Base
ISSN 1475-2077 www.i-Base.info
Watch for out-of-date information
First questions
You and your doctor Resistance and adherence Treatment choices
Recomendaciones para un enfoque de salud pública
Segunda edición 2016
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
Supplement Article
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018 www.jaids.com
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
UNAIDS 2018, Guidance
Indicators for monitoring the
2016 Political Declaration on Ending AIDS
Meeting report, 25-26 September 2017 Copenhagen, Denmark
Journal of Virus Eradication 2018; 4 (Supplement 2): 33–39
